Search

You searched for "networking"

1481 results found

Retinoblastoma management update (part 2): treatment, screening and surveillance, long-term follow-up and new developments

1 February 2017 | | EYE - Oncology
Retinoblastoma treatment requires significant multidisciplinary input, but early detection through raising awareness remains key to improving outcomes. In the second article of a two-part series, Manoj Parulekar discusses retinoblastoma management, screening and research. This article has been published in two...

Principles of management

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - Pathology
Whatever section of pathology is to blame and wherever it strikes, the aim of treatment is always the same. Find the cause if you can. Establish the effects of the cause. Halt the pathological process if you can. Reverse its...

Stem cell therapy for Parkinson’s disease: researching for an 
effective cure

1 December 2015 | | EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...

Patient and public participation shapes biomedical research and access priorities in eye health

1 December 2014 | | EYE - General
Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...

Corporate M&A pace gathers momentum

1 October 2019 | | EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Corneal transplantation in the United Kingdom: are we blind to the challenges that still exist after the Organ Donation Bill?

28 November 2022 | | EYE - Cornea, EYE - General
Corneal transplantation (CT) is a significant treatment option for a huge number of patients in the United Kingdom (UK) [1]. For an individual, CT results in a substantial improvement in quality of life. Penetrating keratoplasty with full thickness grafting has...

Optical practices to continue to provide urgent and essential care

25 March 2020
The UK Government has now published further guidance clarifying that opticians are exempt from the general requirement for retail businesses and premises to close. Optical practices may therefore continue to provide urgent and essential eye care to the extent that they can, including remote care, while managing COVID-19 risk to keep patients, staff and the public as safe as possible.

100% Optical and Optrafair organisers join forces

27 July 2020
From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.

RCOphth Annual Congress - Day 1

23 May 2022 |
Follow all the updates from the first day of the RCOphth 2022 Annual Congress here.

RCOphth Annual Congress - Day 4

26 May 2022 |
Live updates from the final day at the RCOphth 2022 Annual Congress.

Inequities in access to education for blind and partially sighted children

21 June 2023 | Sight Scotland, RNIB, Education, Children, health policy
Leading Scottish vision impairment organisations call on Scottish Government to endorse new framework for vision impairment education.

World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness

22 September 2023 | oculomics, AI, moorfields, big data, RETFound, ChatGPT, UCL, artificial intelligence
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.